19:00 , Jan 18, 2019 |  BC Week In Review  |  Company News

Five Prime cuts headcount by 20%

Five Prime Therapeutics Inc. (NASDAQ:FPRX) said it will reduce headcount by 41 (20%). Cuts will come from research, pathology and manufacturing. The cancer company’s pipeline includes five programs. Its lead compound, bemarituzumab, is in Phase...